First Mercantile Trust’s Agios Pharmaceuticals AGIO Stock Holding History

First Mercantile Trust’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,529	Closed	-$54K	–	844
2020 Q1	$54K	Buy	1,529 +70	+5%	+$3.23K	0.01%	684
2019 Q4	$70K	Buy	1,459 +101	+7%	+$3.82K	0.01%	753
2019 Q3	$44K	Buy	+1,358	New	+$56.2K	﹤0.01%	828
2017 Q1	–	Sell	-2,658	Closed	-$111K	–	823
2016 Q4	$111K	Buy	2,658 +58	+2%	+$3.04K	0.02%	733
2016 Q3	$137K	Buy	+2,600	New	+$113K	0.02%	670
2015 Q1	–	Sell	-2,783	Closed	-$312K	–	1080
2014 Q4	$312K	Buy	2,783 +1,683	+153%	+$150K	0.03%	614
2014 Q3	$67K	Buy	+1,100	New	+$47.4K	0.01%	961

Other funds holding AGIO

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

First Mercantile Trust's AGIO Position: Q2 2020 in Review

First Mercantile Trust sold out of Agios Pharmaceuticals (AGIO) in Q2 2020, closing a stake of 1,529 shares — an estimated $54K sold.

First Mercantile Trust first reported a position in AGIO in Q3 2014 and held it in 7 quarters. The position peaked at $312K in Q4 2014. 217 funds tracked by Wall St. Rank hold AGIO as of Q2 2020.

First Mercantile Trust reported no remaining Agios Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
First Mercantile Trust sold 1,529 Agios Pharmaceuticals shares in Q2 2020, an estimated $54K.
First Mercantile Trust first reported a position in Agios Pharmaceuticals in Q3 2014 and held it in 7 quarters.
First Mercantile Trust's Agios Pharmaceuticals position peaked at $312K in Q4 2014.
217 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2020.

Based on First Mercantile Trust's 13F filing for Q2 2020, filed 10 Aug 2020.